- Trials with a EudraCT protocol (118)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
118 result(s) found for: Charcot.
Displaying page 1 of 6.
EudraCT Number: 2018-003724-36 | Sponsor Protocol Number: CODIF-008 | Start Date*: 2020-04-24 | |||||||||||
Sponsor Name:Ole Lander Svendsen | |||||||||||||
Full Title: The DENOCHARCOT trial Efficacy of treatment with DENOsumab of an acute CHARCOT foot in patients with diabetes. A multicenter, double-blind, randomized, placebo-controlled trial. | |||||||||||||
Medical condition: acute Charcot foot (Charcot arthropathy; ICD-10: DM14.6) in patients with diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001716-36 | Sponsor Protocol Number: 6100 | Start Date*: 2015-08-03 | |||||||||||
Sponsor Name:HÔPITAUX UNIVERSITAIRES DE STRASBOURG | |||||||||||||
Full Title: LONG TERM EFFECT AND TOLERANCE OF ULIPRISTAL ACETATE IN Charcot-Marie-TOOTH DISEASE TYPE 1A (UPACOMT) | |||||||||||||
Medical condition: Charcot-Marie-Tooth disease type 1A | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023097-40 | Sponsor Protocol Number: CLN-PXT3003-01 | Start Date*: 2010-11-29 | |||||||||||
Sponsor Name:Pharnext | |||||||||||||
Full Title: A Phase II, Randomised, Placebo-Controlled Trial of the Safety, Efficacy, Pharmacodynamics of PTX3003 in Patients with Charcot-Marie-Tooth Disease Type 1A | |||||||||||||
Medical condition: Charcot-Marie-Tooth disease (type 1A). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004805-30 | Sponsor Protocol Number: CLN-PXT3003-06 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Pharnext SCA | |||||||||||||
Full Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth type 1A (CMT1A) | |||||||||||||
Medical condition: Charcot Marie Tooth Type 1A | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) BE (Completed) NL (Prematurely Ended) DK (Ongoing) ES (Prematurely Ended) IT (Prematurely Ended) FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002378-19 | Sponsor Protocol Number: CLN-PXT3003-02 | Start Date*: 2015-08-27 | |||||||||||
Sponsor Name:PHARNEXT | |||||||||||||
Full Title: International, multi-center, randomized, double-blind, placebo-controlled phase III study assessing in parallel groups the efficacy and safety of 2 doses of PXT3003 in patients with Charcot-Marie-T... | |||||||||||||
Medical condition: Charcot-Marie-Tooth Disease - Type 1A | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Suspended by CA) ES (Completed) BE (Completed) GB (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001150-15 | Sponsor Protocol Number: MD1003CT2015-01-SERENDEM | Start Date*: 2016-03-14 | |||||||||||||||||||||
Sponsor Name:MEDDAY PHARMACEUTICALS | |||||||||||||||||||||||
Full Title: SERENDEM study: MD1003 in patients suffering from demyelinating neuropathies, an open label pilot study | |||||||||||||||||||||||
Medical condition: chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating neuropathy associated with immunoglobulin M (IgM) monoclonal gammopathy and antibodies against myelin-associated glycoprotei... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-002379-81 | Sponsor Protocol Number: CLN-PXT3003-03 | Start Date*: 2017-01-26 | |||||||||||
Sponsor Name:Pharnext | |||||||||||||
Full Title: International, multi-center, double blind 9-month FOLLOW-UP extension study assessing the long term safety and tolerability of PXT3003 in patients with Charcot-Marie-Tooth Disease type 1A. | |||||||||||||
Medical condition: Charcot-Marie-Tooth Disease type 1A | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) DE (Suspended by CA) BE (Completed) NL (Completed) ES (Prematurely Ended) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016873-13 | Sponsor Protocol Number: PTHinCharcotfoot | Start Date*: 2010-04-29 | |||||||||||
Sponsor Name:King’s College Hospital NHS Foundation Trust | |||||||||||||
Full Title: A novel therapy using recombinant human PTH 1-84 to stimulate bone repair and enhance fracture healing in the acute Charcot foot: a double blind placebo controlled phase IV trial | |||||||||||||
Medical condition: Charcot osteoarthropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004275-35 | Sponsor Protocol Number: DFI6174 | Start Date*: 2007-01-08 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel group trial of HMR1766 assessing the efficacy and safety of 3 doses of HMR1766 (25, 100, 200 mg OD) versus placebo with cilostazol, 100 mg B... | |||||||||||||
Medical condition: Peripheral Arterial Disease (PAD) Fontaine stage II (intermittent claudication) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003594-17 | Sponsor Protocol Number: NL59077.018.16 | Start Date*: 2018-05-28 | |||||||||||
Sponsor Name:AMC | |||||||||||||
Full Title: Effects of a single denosumab injection on reduction of total contact cast treatment and consolidation of bonefractures caused by acute Charcotfoot in patients with diabetes mellitus (CHARCOT st... | |||||||||||||
Medical condition: charcot foot | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004091-12 | Sponsor Protocol Number: 1204-01 | Start Date*: 2013-01-07 | |||||||||||
Sponsor Name:Pluristem Ltd. | |||||||||||||
Full Title: A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cel... | |||||||||||||
Medical condition: Intermittent Claudication (IC); Fontaine class IIb; Rutherford category 2-3 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003119-62 | Sponsor Protocol Number: ACT4791 | Start Date*: 2006-02-17 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: Double-blind, double-dummy, randomized, parallel group trial of SL650472 (three dose regimens versus placebo and cilostazol), for 24-week improvement of walking distance in patients with stage II p... | |||||||||||||
Medical condition: Peripheral arterial disease (intermittent claudication) Fontaine stage II | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BE (Completed) SE (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000900-17 | Sponsor Protocol Number: ejude001 | Start Date*: 2007-02-13 |
Sponsor Name:The University of Manchester [...] | ||
Full Title: A randomised double-blind placebo controlled trial of the oral bisphosphonate, Alendronate, plus intravenous pamidronate, in active diabetic Charcot neuroarthropathy (CN). | ||
Medical condition: Charcot neuroarthropathy Code: E10.6 Insulin + M14.6 Code: E11.6 Insulin + M14.6 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-002508-13 | Sponsor Protocol Number: PADHIF00704 | Start Date*: 2005-04-13 | |||||||||||
Sponsor Name:Genzyme Europe BV | |||||||||||||
Full Title: A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-Selection Study of Ad2/Hypoxia Inducible Factor HIF-1alfa/VP16 in Patients with Intermittent Claudication. | |||||||||||||
Medical condition: Peripheral Arterial Disease (PAD): Intermittent Claudication (IC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000706-37 | Sponsor Protocol Number: CLLG783X2201 | Start Date*: 2017-11-28 | ||||||||||||||||
Sponsor Name:Novartis Pharma AG | ||||||||||||||||||
Full Title: A Patient and Investigator-blinded, randomized, placebo controlled study of LLG783 in patients with peripheral artery disease (PAD) and intermittent claudication. | ||||||||||||||||||
Medical condition: Peripheral Artery Disease (PAD), Intermittent Claudication | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-005449-19 | Sponsor Protocol Number: | Start Date*: 2013-04-24 | |||||||||||
Sponsor Name:Hull and East Yorkshire Hospitals NHS Trust | |||||||||||||
Full Title: A double-blind, randomised controlled trial of percutaneous transluminal angioplasty (PTA) & Ramipril versus PTA & placebo in the management of intermittent claudication (IC) | |||||||||||||
Medical condition: Peripheral Arterial Disease: Intermittent Claudication | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002382-62 | Sponsor Protocol Number: RNS60-ALS | Start Date*: 2017-01-13 | |||||||||||||||||||||
Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI | |||||||||||||||||||||||
Full Title: The effects of RNS60 on ALS biomarkers | |||||||||||||||||||||||
Medical condition: Amyotrophic Lateral Sclerosis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004165-17 | Sponsor Protocol Number: 2289/2007 | Start Date*: 2007-09-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Efficacy assessment of ceftriaxone therapy in patients with amyotrophic lateral sclerosis. | |||||||||||||
Medical condition: Amyotrophic lateral sclerosis (ALS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020010-28 | Sponsor Protocol Number: EDTA | Start Date*: 2010-09-22 | |||||||||||
Sponsor Name:Dr.ssa Marina Aiello-Universit� degli studi di Parma | |||||||||||||
Full Title: EVALUATION OF RESPIRATORY MUSCLES` FUNCTION IN PATIENTS AFFECTED BY ALS WITH HEAVY METAL POISONING | |||||||||||||
Medical condition: PATIENTS AFFECTED BY ALS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010060-41 | Sponsor Protocol Number: 2707/2009 | Start Date*: 2009-02-24 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Evaluation of efficacy of lithium salts therapy in patients with Amyotrophic Lateral Sclerosis. | |||||||||||||
Medical condition: Amyotrophic Lateral Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.